Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ali Raif İlaç
Istanbul, Istanbul, Turkeyaliraif.com.tr ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Ali Raif İlaç is a prominent Turkish pharmaceutical company established in 1963, dedicated to the production and marketing of essential medicines across a wide range of therapeutic areas. Headquartered in Istanbul, the company operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Its portfolio includes a robust selection of branded generics and licensed products focusing on cardiovascular, gastrointestinal, and central nervous system treatments. Ali Raif maintains strategic partnerships with global pharmaceutical entities to enhance the availability of innovative therapies in the Turkish healthcare market.
- Therapeutic areas
- ImmunologyEndocrinologyCardiovascularRheumatologyPulmonologyGastroenterologyPsychiatry
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on Ali Raif İlaç.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ali Raif İlaç.